Skip to content

PHARMARE

Active Private limited companyfounded 2014active for 12 yearsKardinaal Mercierlaan 30, 8420 De HaanKBO/BCE: BE 0553.716.481

Timeline

23 events since 2014
2025
Annual accounts 2025 filed PDFabbreviated format · 27 days late
2024
Annual accounts 2024 filed PDFabbreviated format · 30 days late
2023
Annual accounts 2023 filed PDFabbreviated format · 47 days before the deadline
2022
Annual accounts 2022 filed PDFabbreviated format · 7 days late
changes role from manager to directorDirector discharge: · General meeting of 09-05-20225 points ▸
  • General meeting, 09-05-2022
  • Director resignation, (manager)
  • Director appointment, (director (not named in the articles))
  • Director discharge,
  • Registered office clause, Kardinaal Mercierlaan 30, 8420 De Haan
  • The deed holds 4 more points.

Open the deed in the Belgian Official Gazette

Highest result from 2015 to 2025 net €264,551 ▲102% The operating result of €283,455 and the net result of €264,551 are both a record.
Equity above €500,000 equity €543,402 ▲94.9% After 2 profitable years in a row, equity reaches €543,402.
2021
Annual accounts 2021 filed PDFabbreviated format · 17 days before the deadline
Back to profit net €130,879 The net result is €130,879, after one loss-making year.
Liquidity more than 15 times current ratio 1.98 The current ratio rises from 0.13 to 1.98.
2020
Annual accounts 2020 filed PDFabbreviated format · 17 days late
Weakest financial year net -€89,618 The net result drops to -€89,618, the lowest from 2015 to 2025. It recovers the following year.
2019
Annual accounts 2019 filed PDFabbreviated format · 37 days before the deadline
Environmental permit granted Verbouwen en/of uitbreiden met functiewijziging en met wijziging van aantal woongelegenheden · Blankenberge
Equity above €200,000 equity €237,589 ▲40.3% With a profit in every financial year since 2015, equity grows to €237,589.
2018
Annual accounts 2018 filed PDFabbreviated format · 47 days before the deadline
Equity above €150,000 equity €169,290 ▲18.5% With a profit in every financial year since 2015, equity grows to €169,290.
2017
Annual accounts 2017 filed PDFabbreviated format · 18 days before the deadline
Equity above €100,000 equity €142,840 ▲79.4% With a profit in every financial year since 2015, equity grows to €142,840.
2016
Annual accounts 2016 filed PDFabbreviated format · 31 days before the deadline
2015
Annual accounts 2015 filed PDFabbreviated format · 24 days late
2014
IncorporationFounding capital of €25,000, 1,000 shares, €10,000 paid up · Founded by ; · appointed as manager · published on 12-06-20146 points ▸
  • Founder,
  • Founder,
  • Registered office clause, Kardinaal Mercierlaan 30, 8420 De Haan
  • Capital, €25,000, 1,000 shares
  • Director appointment, (manager (not named in the articles))
  • Founding capital, €25,000, 1,000 shares
  • The deed holds 2 more points.

Open the deed in the Belgian Official Gazette

First establishment Kardinaal Mercierlaan 30, De Haan

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

On 10 June 2014, PHARMARE was incorporated by two private individuals, with a starting capital of €25,000.12 is director of the company, appointed by deed of 30-05-2022.3 Total assets went from €1.1m in 2019 to €1.3m in 2025.4

  1. 1KBO register
  2. 2Belgian Official Gazette, 12-06-2014
  3. 3Belgian Official Gazette, 30-05-2022
  4. 4National Bank, annual accounts 2019 and 2025

Next steps